Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Report and Accounts

Vernalis plc - AR 30-06-2016 - FINAL - COVER PAGE WEBSITE

30 June, 2016

2015/16 Results Download our latest report...

Archive

Latest Presentation

ceo01 December, 2016

Our latest presentation is available to view from here...


Archive

Share Price

Share price:  34.75p
Change:  0.88 (2.58%)
As at:  09 December 2016 18:15:01
Volume:  7,656
LSE ID:  VER

Share price details

Latest News

AGM Statement

Vernalis plc ("Vernalis" or the "Company") provides an update ahead of its Annual General Meeting ("AGM") being held today at 11.00 am at the offices of Covington & Burling, 265 Strand, London WC2R 1BH.

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch